This inventor holds 4 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Novmetapharma Co., Ltd., Seoul National University, Novmetapharma Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pohang-si, KR (2023 - 2024)
- Gyeongsangbuk-do, KR (2024)
Company Filing History:
3 out of 15 
2 out of 1,789 
1 out of 4 Years Active: 2023-2026
Title: The Innovations of Do Hyun Lee
Introduction
Do Hyun Lee is a prominent inventor based in Pohang-si, South Korea. He has made significant contributions to the field of medical treatments, particularly in the areas of fibrosis and bone loss diseases. With a total of 4 patents, his work showcases innovative approaches to addressing critical health issues.
Latest Patents
One of his latest patents is a method of treating fibrosis, which discloses a new use of cyclo(His-Pro). This method involves administering an effective amount of an isolated cyclo(His-Pro) to a subject in need, providing a novel approach to treating fibrosis and inflammation. Another significant patent is a composition comprising cyclo-His-Pro (CHP) for preventing, improving, or treating bone loss-related diseases. This composition contains CHP or a CHP-containing prostate extract, highlighting its potential in addressing bone loss diseases.
Career Highlights
Do Hyun Lee has worked with notable organizations, including Novmetapharma Co., Ltd. and Seoul National University. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
He has collaborated with esteemed colleagues such as Hoe Yune Jung and Heon Jong Lee, further enhancing the impact of his research and inventions.
Conclusion
Do Hyun Lee's contributions to the field of medical innovation are noteworthy. His patents reflect a commitment to improving health outcomes through scientific advancements. His work continues to inspire future innovations in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile